Buy Doxepin

Doxepin

Doxepin: Antidepressant Pill Overview

Therapeutic class: Antidepressants - Tricyclic antidepressant (TCA) Active ingredient: Doxepin Formulation: Oral pill (tablet/capsule) Strengths available: 10 mg, 25 mg, 75 mg Regulatory status in Hong Kong: Prescription-only medication, approved by the Hong Kong Department of Health for the treatment of major depressive disorder.

How Doxepin Works in the Body

Doxepin belongs to the tricyclic antidepressant family. It primarily blocks the reuptake of two key neurotransmitters-norepinephrine and serotonin-thereby increasing their concentrations in the synaptic cleft and improving mood regulation. At lower doses, Doxepin also exhibits strong antihistamine activity by antagonizing H₁ receptors, which accounts for its sedative effect in some patients.

• Onset of action: Clinical improvement usually begins within 2-4 weeks of regular dosing.
• Peak effect: Maximal therapeutic benefit is often reached after 6-8 weeks.
• Duration of action: The drug’s half-life ranges from 15 to 30 hours, allowing once-daily or twice-daily dosing schedules.

Conditions Treated by Doxepin

• Major depressive disorder (MDD): The primary indication approved by Hong Kong health authorities. Doxepin is prescribed for adults experiencing moderate to severe depressive episodes.
• Adjunctive use for chronic anxiety (off-label): Some clinicians employ Doxepin to augment anxiety management, but this requires careful assessment and is not an approved indication in Hong Kong.

Note: Low-dose Doxepin for insomnia is approved in several jurisdictions (e.g., United States) but is not formally indicated in Hong Kong. Use for sleep must be guided by a specialist.

Patient Suitability and Contraindications

Who Should Use Doxepin?

• Adults diagnosed with major depressive disorder who have not responded adequately to other antidepressant classes or who have a clinical profile favoring TCA therapy.
• Patients able to follow monitoring requirements (e.g., ECG when indicated).

Absolute Contraindications

• Known hypersensitivity to Doxepin or other tricyclic antidepressants.
• Concurrent use of monoamine oxidase inhibitors (MAOIs) or recent (within 14 days) discontinuation of an MAOI.
• Recent myocardial infarction or unstable cardiac disease.

Relative Contraindications

• Pregnancy & lactation: Doxepin crosses the placenta and is excreted in breast milk. Use only if the potential benefit outweighs fetal risk; generally avoided in the first trimester.
• Elderly patients: Increased susceptibility to anticholinergic side effects and cardiac arrhythmias; start at the lowest effective dose and monitor closely.
• Severe hepatic impairment: Reduced metabolism may require dose reduction.
• Renal insufficiency: Adjust dosing when creatinine clearance falls below 30 mL/min.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Dry mouth
• Constipation
• Sedation or drowsiness (more common at lower doses)
• Blurred vision
• Weight gain

These effects are usually mild to moderate and often diminish with continued therapy. Staying hydrated, consuming a high-fiber diet, and avoiding driving until the sedative effect is known can help manage them.

Serious Adverse Events

• Cardiac arrhythmias, including QT-interval prolongation and torsades de pointes.
• Seizures, especially at high doses or in patients with a seizure disorder.
• Serotonin syndrome when combined with other serotonergic agents.
• Severe orthostatic hypotension leading to falls.

If any of the following occur, seek emergency medical attention: palpitations, fainting, uncontrolled tremor, high fever, or severe confusion.

Drug Interactions

• Major: MAO inhibitors (risk of hypertensive crisis and serotonin syndrome).
• Moderate: CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) can increase Doxepin plasma levels; CYP2D6 inducers (e.g., rifampin) may lower efficacy.
• Serotonergic agents: SSRIs, SNRIs, tramadol, and certain herbal supplements (e.g., St. John’s wort) raise the risk of serotonin syndrome.
• Anticholinergic drugs: Concomitant use may exacerbate dry mouth, constipation, and urinary retention.

Food and Lifestyle Interactions

• Alcohol: Potentiates sedation and may increase the risk of hypotension.
• Food: Doxepin can be taken with or without meals; a consistent routine helps maintain stable blood levels.
• Driving: Avoid operating machinery until the individual’s response to the medication is known, especially during dose initiation.

Dosing and Administration Guidelines

Standard adult dosing for depression

• Initial dose: 75 mg once daily, usually divided into morning and evening doses (e.g., 25 mg + 50 mg).
• Titration: Increase by 25-50 mg at weekly intervals based on clinical response and tolerability.
• Typical maintenance range: 150 mg to 300 mg per day, administered in divided doses.

Low-dose regimens (often used off-label for sleep)

• 10 mg taken once nightly, on an empty stomach to reduce daytime sedation.

Special populations

• Elderly: Start at 25 mg per day; titrate slowly.
• Hepatic impairment: Reduce initial dose by 25-50 % and adjust based on liver function tests.
• Renal impairment: Use the lowest effective dose; monitor serum creatinine.

Administration tips

• Swallow the pill whole with a full glass of water.
• Do not crush or chew extended-release formulations (if present).
• If a dose is missed and it is less than 12 hours until the next scheduled dose, take it as soon as remembered; otherwise skip and resume the regular schedule. Do not double the dose.

Overdose management

• Symptoms may include severe drowsiness, cardiac arrhythmias, seizures, and coma.
• Immediate medical attention is required; supportive care and cardiac monitoring are standard.
• No specific antidote; activated charcoal may be considered if presentation is early.

Discontinuation

• Gradual tapering is advised to reduce the risk of withdrawal symptoms such as dizziness, irritability, and flu-like sensations. A typical taper reduces the dose by 25 mg every 1-2 weeks under medical supervision.

Monitoring and Follow-Up

• Baseline ECG: Recommended for all patients, especially those with cardiac risk factors, to assess QT interval.
• Periodic ECGs: Repeat if dose exceeds 300 mg/day or if the patient develops cardiac symptoms.
• Liver function tests: Check at baseline and periodically in patients with hepatic disease.
• Renal function: Monitor serum creatinine in patients with known kidney disease.
• Clinical assessment: Evaluate depressive symptom scores (e.g., PHQ-9) every 4-6 weeks during the titration phase.

Storage and Handling

• Keep the pills in their original container, tightly closed.
• Store at room temperature (20 °C-25 °C) away from excess moisture and direct sunlight.
• Do not use if the tablets appear discolored or fragmented.
• Dispose of unused medication according to local pharmacy or waste-management guidelines; do not flush.

Medication-Specific Glossary

Tricyclic antidepressant (TCA)

A class of older-generation antidepressants that block the reuptake of norepinephrine and serotonin and possess anticholinergic properties.

Anticholinergic

Refers to a drug’s ability to inhibit the action of acetylcholine, often leading to dry mouth, constipation, and blurred vision.

QT prolongation

An extension of the heart’s electrical repolarization phase; can predispose to dangerous arrhythmias.

Serotonin syndrome

A potentially life-threatening condition caused by excessive serotonergic activity, characterized by agitation, hyperreflexia, rapid heart rate, and high fever.

Therapeutic window

The dosage range within which a drug provides efficacy without causing unacceptable toxicity.

Medical Disclaimer

This article provides educational information about Doxepin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.